Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mallampati Class Zero airway: a narrative review.
Sepúlveda Haro E, Raigón Ponferrada A, Ramírez Aliaga M, Galache Laza M, Guerrero Orriach JL, Mañas JC. Sepúlveda Haro E, et al. Among authors: manas jc. Minerva Anestesiol. 2022 May;88(5):390-395. doi: 10.23736/S0375-9393.21.15945-0. Epub 2021 Oct 12. Minerva Anestesiol. 2022. PMID: 34636224 Review.
NGS of microRNAs Involved in Cardioprotection Induced by Sevoflurane Compared to Propofol in Myocardial Revascularization Surgery: The ACDHUVV-16 Clinical Trial.
Orriach JLG, Belmonte JJE, Aliaga MR, Fernandez AR, Capitan MJR, Muñoz GQ, Ponferrada AR, Torres JA, Santiago-Fernandez C, Gonzalez EM, Navarro MR, Bautista R, Maldonado JG, Garrido-Sanchez L, Mañas JC. Orriach JLG, et al. Among authors: manas jc. Curr Med Chem. 2021;28(20):4074-4086. doi: 10.2174/0929867327999201001202607. Curr Med Chem. 2021. PMID: 33023430 Clinical Trial.
Anaesthesia and cancer: can anaesthetic drugs modify gene expression?
Ponferrada AR, Orriach JLG, Manso AM, Haro ES, Molina SR, Heredia AF, Lopez MB, Mañas JC. Ponferrada AR, et al. Among authors: manas jc. Ecancermedicalscience. 2020 Jul 27;14:1080. doi: 10.3332/ecancer.2020.1080. eCollection 2020. Ecancermedicalscience. 2020. PMID: 32863874 Free PMC article. Review.
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients.
Gligorov J, Ataseven B, Verrill M, De Laurentiis M, Jung KH, Azim HA, Al-Sakaff N, Lauer S, Shing M, Pivot X; SafeHer Study Group. Gligorov J, et al. Eur J Cancer. 2017 Sep;82:237-246. doi: 10.1016/j.ejca.2017.05.010. Epub 2017 Jun 16. Eur J Cancer. 2017. PMID: 28625777 Clinical Trial.
Defining the optimal sequence for the systemic treatment of metastatic breast cancer.
Mestres JA, iMolins AB, Martínez LC, López-Muñiz JI, Gil EC, de Juan Ferré A, Del Barco Berrón S, Pérez YF, Mata JG, Palomo AG, Gregori JG, Pardo PG, Mañas JJ, Hernández AL, de Dueñas EM, Jáñez NM, Murillo SM, Bofill JS, Auñón PZ, Sanchez-Rovira P. Mestres JA, et al. Among authors: manas jj. Clin Transl Oncol. 2017 Feb;19(2):149-161. doi: 10.1007/s12094-016-1520-2. Epub 2016 Jun 17. Clin Transl Oncol. 2017. PMID: 27314861 Free PMC article.
14 results